Eli Lilly and Company

Healthcare

Big Pharma Uses Subsidies for Rare Diseases to Develop Blockbuster Drugs

Photo by Nappy via Unsplash

The US government designed a program to incentivize the development of treatments for rare tropical diseases. Big Pharma had other plans.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.